0001127602-23-027436.txt : 20231115
0001127602-23-027436.hdr.sgml : 20231115
20231115163236
ACCESSION NUMBER: 0001127602-23-027436
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hill, Mitch C.
CENTRAL INDEX KEY: 0001644989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 231411040
MAIL ADDRESS:
STREET 1: 1009 TENNYSON DRIVE
CITY: SOUTHLAKE
STATE: TX
ZIP: 76902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-11-13
0001531048
Inari Medical, Inc.
NARI
0001644989
Hill, Mitch C.
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
Chief Financial Officer
1
Common Stock
2023-11-13
4
M
0
6500
.457
A
176730
D
Common Stock
2023-11-13
4
S
0
1600
55.49
D
175130
D
Common Stock
2023-11-13
4
S
0
4500
56.18
D
170630
D
Common Stock
2023-11-13
4
S
0
400
56.93
D
170230
D
Common Stock
1600
I
By Spouse
Stock Options (Right to Buy)
.457
2023-11-13
4
M
0
6500
0
D
2029-04-23
Common Stock
6500
100977
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
This transaction was executed in multiple trades at prices ranging from $54.82 to $55.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $55.82 to $56.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $56.82 to $57.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter.
/s/ Shannon Trevino, attorney-in-fact for Mitch C. Hill
2023-11-15